Nephrada · FSGS · France · Renal pathologist · captured by Dr. Anna Becker on 01 Feb 2026 · reviewed by Dr. Marcus Lindqvist on 06 Feb 2026
Verbatim as captured; never edited
Renal pathologist at Gustave Roussy raised steroid-sparing strategies during a investigator meeting. They asked whether additional data would be presented at the next congress.
Human-approved by Dr. Marcus Lindqvist on 06 Feb 2026
Steroid-sparing strategies: interest in collaboration reported by renal pathologist (FR).
helixor-private-llm-2026.05 · generated 01 Feb 2026, 10:00 UTC
AI summary
Steroid-sparing strategies raised by renal pathologist; aligns with HEOR.
Source spans used by the model
Renal pathologist at Gustave Roussy raised steroid-sparing strategies during a investigator meeting. They asked whether additional data would be presented at the next congress.
| Field | AI suggestion | Final (human-approved) |
|---|---|---|
| Category | Education need | Evidence gap |
| Function | HEOR | HEOR |
| Priority | Medium | Medium |
Transparent weighted model; contribution = value ÷ 5 × weight
| Dimension | Value (1–5) | Weight | Contribution |
|---|---|---|---|
| Patient relevance | 4 | 20% | 16.0 |
| Strategic alignment | 1 | 20% | 4.0 |
| Scientific importance | 2 | 15% | 6.0 |
| Urgency | 2 | 15% | 6.0 |
| Novelty | 4 | 10% | 8.0 |
| Actionability | 4 | 10% | 8.0 |
| Confidence | 5 | 5% | 5.0 |
| Breadth of occurrence | 2 | 5% | 2.0 |
| Total | Medium 55 | ||
No audit events in sample data
Every model call on this record and its human outcome
No AI interactions in sample data
Current stage and the next allowed action
Who reviewed, what action, which function, what decision, what outcome, when closed
31 Jan 2026 · Dr. Javier Kimura, Gustave Roussy · MSL Dr. Anna Becker
Insight
Reviewed 06 Feb 2026 by Dr. Marcus Lindqvist
Action
Publication project · David Chen · In progress
Decision
Outcome
Closure
Incorporated into evidence-generation plan.